Axpero 5mg

About Axpero 5mg

Axpero 5mg contains Axitinib, a potent tyrosine kinase inhibitor (TKI) specifically designed to target vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3). Manufactured by Intas Pharmaceuticals Ltd, this life-saving medication works by blocking signals that promote tumour blood vessel formation, effectively starving cancer cells of nutrients and oxygen. Axitinib is clinically proven for treating advanced renal cell carcinoma (kidney cancer) after failure of prior systemic therapy. By inhibiting angiogenesis, the process through which tumours develop new blood vessels, Axpero helps control tumour growth and progression. Similar to how Bosuvi 100mg targets specific kinase pathways in other cancers, Axitinib provides targeted therapy with fewer systemic side effects compared to traditional chemotherapy agents like Celgem 200mg.

Dosage & Usage

The recommended starting dose of Axpero is 5mg taken orally twice daily, approximately 12 hours apart. Tablets should be swallowed whole with water and can be taken with or without food, though consistency is important. Your oncologist may adjust the dose based on individual tolerance and blood pressure management, doses may be increased to 7mg or 10mg twice daily, or reduced to 3mg or 2mg twice daily if side effects occur. Never exceed the prescribed dose without medical supervision. Treatment typically continues until disease progression or unacceptable toxicity occurs. Missing a dose should not prompt doubling the next one; simply resume your regular schedule. Regular blood pressure monitoring is essential throughout treatment, as hypertension is a common effect.

Who Is It For?

Axpero 5mg is prescribed for adults with advanced renal cell carcinoma who have not responded to or progressed after initial treatment with sunitinib or a cytokine-based therapy. It is particularly beneficial for patients seeking targeted therapy with manageable side effects. However, Axitinib is contraindicated in patients with severe hepatic impairment, uncontrolled hypertension, or recent bleeding events. It should not be used during pregnancy or breastfeeding due to potential harm to the developing foetus. Patients requiring other targeted cancer therapies may also benefit from alternatives like Afanat 30mg for specific EGFR-positive tumours. Always inform your oncologist of all medications you're taking, as Axitinib interacts with strong CYP3A4/5 inhibitors and inducers.

Why Buy From SafeRxPills?

SafeRxPills is a licensed online pharmacy delivering genuine WHO-GMP certified Axpero 5mg to patients across the USA, UK, Australia, and Canada. We understand the sensitivity of cancer treatment and guarantee 100% discreet shipping in plain, unmarked packaging with no external pharmacy labelling. All orders are dispatched securely with delivery typically within 7-14 business days. Every medication comes with authentic batch verification, ensuring you receive legitimate Intas Pharmaceuticals products. Our licensed pharmacists are available to answer questions about your prescription, and our encrypted checkout process protects your privacy at every step.